In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAMES: Actigall (Watson); Adursall; Arsacol; Biliepar; Cholacid; Cholit-Ursan; Cholofalk; Coledos; Delursan; Desocol; Desoxil; Destolit (Norgine); Deurcil; Dexo; Estazor; Fraurs; Galmax; Lentorsil; Litanin; Litocure; Litoff; Litursol; Lyeton; Peptaron; Solutrat; UDC; UDC Hexal; Urdox (Wockhardt); Urso 250 (Aptalis); Urso Forte (Aptalis); Urso Heumann; Urso Vinas; Ursochol; Ursofal; Ursofalk; Ursoflor; Ursogal (Galen); Ursolac; Ursolism; Ursolvan; Urson; Ursoproge; Ursosan; Ursotan; USCA
- INDICATIONS: The dissolution of radiolucent (i.e. non-radio opaque) cholesterol gallstones in patients with a functioning gallbladder; primary biliary cirrhosis; biliary calculus; cholelithiasis
- SYNONYM: ursodeoxycholic acid; UDCA
- CLASS: Cholesterol antagonist, Urolithic
- HALF-LIFE: 100 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aluminum based antacids, Aluminum hydroxide, Charcoal, Cholestyramine, Clofibrate, Colestimide, Colestipol, Cyclosporine, Dapsone, Estradiol, Estrogens, Nitrendipine, Oral Contraceptives, P4503A substrates
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
